Nova Mentis Launches Entourage Effect Research
Nova Mentis Life Science Corp (CSE: NOVA) recently announced that it is working on the Entourage Effect. According to NOVA, “It is theorized that psilocybin and mushroom tryptamine derivatives, such …
Learn how ingredients found in naturally occurring mushrooms outperform the leading pharmaceutical antidepressant and anti-anxiety drugs — without the side-effects.
The psilocybin field is underdeveloped. Only one active ingredient in “magic mushrooms” has been formulated and studied in a meaningful way.
The pharmaceutical industry has failed to create safe and effective chemical compositions for treating mood disorders, such as depression, anxiety, compulsion, addiction, etc.
The psilocybin field needs to shift its focus from “magic mushrooms” to the active molecules within them.
We can make better products for treating mood disorders by formulating naturally occurring psilocybin derivatives.
Nova Mentis Life Science Corp (CSE: NOVA) recently announced that it is working on the Entourage Effect. According to NOVA, “It is theorized that psilocybin and mushroom tryptamine derivatives, such …
The New Amsterdam Psychedelic Law blog recently published a video discussion between Graham Pechenik and Noah Potter about “Who owns psychedelics: patents and state therapeutic access laws.” The blog is …
Over the past several months, MindMed has taken two important steps towards the next generation of psychedelic compositions — formulations that harness the Entourage Effect. First, MindMed recognized the potential …
Compass Pathways Plc. has developed a crystalline form of psilocybin (COMP360) that makes other crystals (like the Hope Diamond, pictured above) look cheap. Over the last four years, Compass has …
Is MagicMed Industries Inc. the first patent troll to enter the psychedelic space? Or has MagicMed come up with a brilliant plan that will benefit the entire psychedelics industry by …
In an September 3, 2020 press release on Psilocybin Alpha, Aion Therapeutics reported that it was “pleased to announce that the Company has filed five patent applications with the United …
In previous articles, Psilocybin Technology wrote about the emerging psychedelics industry and its newfound focus on intellectual property. The recent and dramatic increase in patent filings gives rise to questions …
Patents on Psychedelics are No Longer a Novel Idea In January of 2020, we published an article about “Psychedelic Investment Opportunities,” in which reiterated our earlier position (from 2019) that …